A novel nonhuman primate model for influenza transmission

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Moncla, Louise H ^a,b,c   Ross, Ted M ^d,e   Dinis, Jorge M ^a,b,c   Weinfurter, Jason T ^a,b   Mortimer, Tatum D ^a,b,c   Schultz Darken, Nancy ^b   Brunner, Kevin ^b   Capuano III, Saverio V ^b   Boettcher, Carissa ^b   Post, Jennifer ^b   Johnson, Michael ^b   Bloom, Chalise E ^e   Weiler, Andrea M ^b   Friedrich, Thomas C ^a,b,c  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e Vaccine and Gene Therapy Institute of Florida   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; CALLITHRIX; DISEASE MODELS, ANIMAL; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MODELS, BIOLOGICAL; VIRUS REPLICATION;

EID: 84893667207     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078750     Document Type: Article

References (47)

1. Bodewes R, Rimmelzwaan GF, Osterhaus AD (2010) Animal models for the preclinical evaluation of candidate influenza vaccines. Expert Rev Vaccines 9: 59-72.
2. Bouvier NM, Lowen AC (2010) Animal Models for Influenza Virus Pathogenesis and Transmission. Viruses 2: 1530-1563.
3. Mansfield K (2003) Marmoset models commonly used in biomedical research. Comp Med 53: 383-392.
4. Imai M, Watanabe T, Hatta M, Das SC, Ozawa M, et al. (2012) Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 486: 420-428.
5. United States National Research Council (1996) Guide for the care and use of laboratory animals.
6. WHO (2002) WHO Manual on Animal Influenza Diagnosis and Surveillance.
7. Carrat F, Vergu E, Ferguson NM, Lemaitre M, Cauchemez S et al. (2008) Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol 167: 775-785. (Pubitemid 351451744)
8. Liem NT, Tung CV, Hien ND, Hien TT, Chau NQ, et al. (2009) Clinical features of human influenza A (H5N1) infection in Vietnam: 2004-2006. Clin Infect Dis 48: 1639-1646.
9. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, Hernandez M, Quinones-Falconi F, et al. (2009) Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 361: 680-689.
10. Yuen KY, Chan PK, Peiris M, Tsang DN, Que TL, et al. (1998) Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 351: 467-471. (Pubitemid 28070092)
11. Lin KL, Sweeney S, Kang BD, Ramsburg E, Gunn MD (2011) CCR2-antagonist prophylaxis reduces pulmonary immune pathology and markedly improves survival during influenza infection. J Immunol 186: 508-515.
12. Hoffmann E, Stech J, Guan Y, Webster RG, Perez DR (2001) Universal primer set for the full-length amplification of all influenza A viruses. Arch Virol 146: 2275-2289. (Pubitemid 34682391)
13. Kofler R, Orozco-terWengel P, De Maio N, Pandey RV, Nolte V, et al. (2011) PoPoolation: a toolbox for population genetic analysis of next generation sequencing data from pooled individuals. PLoS One 6: e15925.
14. Weinfurter JT, Brunner K, Capuano SVr, Li C, Broman KW, et al. (2011) Cross-reactive T cells are involved in rapid clearance of 2009 pandemic H1N1 influenza virus in nonhuman primates. PLoS Pathog 7: e1002381.
15. Tajima F (1983) Evolutionary relationship of DNA sequences in finite populations. Genetics 105: 437-460.
16. Jegaskanda S, Weinfurter JT, Friedrich TC, Kent SJ (2013) Antibody-dependent cellular cytotoxicity (ADCC) is associated with control of pandemic H1N1 influenza virus infection of macaques. J Virol 87: 5512-5522.
17. Carter DM, Bloom CE, Nascimento EJ, Marques ET, Craigo JK, et al. (2013) Sequential seasonal H1N1 influenza virus infections protect ferrets against novel 2009 H1N1 influenza virus. J Virol 87: 1400-1410.
18. Tellier R (2006) Review of aerosol transmission of influenza A virus. Emerg Infect Dis 12: 1657-1662.
19. Nicas M, Nazaroff WW, Hubbard A (2005) Toward understanding the risk of secondary airborne infection: emission of respirable pathogens. J Occup Environ Hyg 2: 143-154. (Pubitemid 40397039)
20. Edenborough KM, Gilbertson BP, Brown LE (2012) A mouse model for the study of contact-dependent transmission of influenza A virus and the factors that govern transmissibility. J Virol 86: 12544-12551.
21. Edwards DA, Man JC, Brand P, Katstra JP, Sommerer K, et al. (2004) Inhaling to mitigate exhaled bioaerosols. Proc Natl Acad Sci U S A 101: 17383-17388. (Pubitemid 39657413)
22. Xie X, Li Y, Sun H, Liu L (2009) Exhaled droplets due to talking and coughing. J R Soc Interface 6 Suppl 6: S703-14.
23. Cauchemez S, Donnelly CA, Reed C, Ghani AC, Fraser C, et al. (2009) Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. N Engl J Med 361: 2619-2627.
24. Carcione D, Giele CM, Goggin LS, Kwan KS, Smith DW, et al. (2011) Secondary attack rate of pandemic influenza A(H1N1) 2009 in Western Australian households, 29 May-7 August 2009. Euro Surveill 16: 19765.
25. Sikora C, Fan S, Golonka R, Sturtevant D, Gratrix J, et al. (2010) Transmission of pandemic influenza A (H1N1) 2009 within households: Edmonton, Canada. J Clin Virol 49: 90-93.
26. Maines TR, Jayaraman A, Belser JA, Wadford DA, Pappas C, et al. (2009) Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science 325: 484-487.
27. Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, et al. (2009) In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 460: 1021-1025.
28. Zhang Y, Zhang Q, Gao Y, He X, Kong H, et al. (2012) Key molecular factors in hemagglutinin and PB2 contribute to efficient transmission of the 2009 H1N1 pandemic influenza virus. J Virol 86: 9666-9674.
29. Omatsu T, Moi ML, Hirayama T, Takasaki T, Nakamura S, et al. (2011) Common marmoset (Callithrix jacchus) as a primate model of dengue virus infection: development of high levels of viraemia and demonstration of protective immunity. J Gen Virol 92: 2272-2280.
30. Smither SJ, Nelson M, Eastaugh L, Laws TR, Taylor C, et al. (2013) Experimental respiratory Marburg virus haemorrhagic fever infection in the common marmoset (Callithrix jacchus). Int J Exp Pathol
31. Smith DR, Bird BH, Lewis B, Johnston SC, McCarthy S, et al. (2012) Development of a novel nonhuman primate model for Rift Valley fever. J Virol 86: 2109-2120.
32. Leibovitch E, Wohler JE, Cummings Macri SM, Motanic K, Harberts E, et al. (2013) Novel marmoset (Callithrix jacchus) model of human Herpesvirus 6A and 6B infections: immunologic, virologic and radiologic characterization. PLoS Pathog 9: e1003138.
33. Chang H, Wachtman LM, Pearson CB, Lee JS, Lee HR, et al. (2009) Nonhuman primate model of Kaposi's sarcoma-associated herpesvirus infection. PLoS Pathog 5: e1000606.
34. Kramski M, Matz-Rensing K, Stahl-Hennig C, Kaup FJ, Nitsche A, et al. (2010) A novel highly reproducible and lethal nonhuman primate model for orthopox virus infection. PLoS One 5: e10412.
35. Jagessar SA, Heijmans N, Blezer EL, Bauer J, Blokhuis JH, et al. (2012) Unravelling the T-cell-mediated autoimmune attack on CNS myelin in a new primate EAE model induced with MOG34-56 peptide in incomplete adjuvant. Eur J Immunol 42: 217-227.
36. Jagessar SA, Heijmans N, Oh L, Bauer J, Blezer EL, et al. (2012) Antibodies against human BLyS and APRIL attenuate EAE development in marmoset monkeys. J Neuroimmune Pharmacol 7: 557-570.
37. Kap YS, van Driel N, Blezer E, Parren PW, Bleeker WK, et al. (2010) Late B cell depletion with a human anti-human CD20 IgG1kappa monoclonal antibody halts the development of experimental autoimmune encephalomyelitis in marmosets. J Immunol 185: 3990-4003.
38. Brok HP, Hornby RJ, Griffiths GD, Scott LA, Hart BA (2001) An extensive monoclonal antibody panel for the phenotyping of leukocyte subsets in the common marmoset and the cotton-top tamarin. Cytometry 45: 294-303.
39. Kireta S, Zola H, Gilchrist RB, Coates PT (2005) Cross-reactivity of anti-human chemokine receptor and anti-TNF family antibodies with common marmoset (Callithrix jacchus) leukocytes. Cell Immunol 236: 115-122. (Pubitemid 41771095)
40. Riecke K, Nogueira AC, Alexi-Meskishvili V, Stahlmann R (2000) Cross-reactivity of antibodies on thymic epithelial cells from humans and marmosets by flow-cytometry. J Med Primatol 29: 343-349. (Pubitemid 32036699)
41. Neubert R, Foerster M, Nogueira AC, Helge H (1996) Cross-reactivity of antihuman monoclonal antibodies with cell surface receptors in the common marmoset. Life Sci 58: 317-324. (Pubitemid 26024088)
42. NIH (2013) NIH Nonhuman Primate Reagent Resource. Available: http://nhpreagents.bidmc.harvard.edu/NHP/default.aspx via the Internet.
43. Drake JW, Holland JJ (1999) Mutation rates among RNA viruses. Proc Natl Acad Sci U S A 96: 13910-13913.
44. Nelson MI, Holmes EC (2007) The evolution of epidemic influenza. Nat Rev Genet 8: 196-205.
45. Alizon S, Luciani F, Regoes RR (2011) Epidemiological and clinical consequences of within-host evolution. Trends Microbiol 19: 24-32.
46. Naffakh N, Tomoiu A, Rameix-Welti MA, van der Werf S (2008) Host restriction of avian influenza viruses at the level of the ribonucleoproteins. Annu Rev Microbiol 62: 403-424.
47. Ince WL, Gueye-Mbaye A, Bennink JR, Yewdell JW (2013) Reassortment Complements Spontaneous Mutation in Influenza A Virus NP and M1 Genes To Accelerate Adaptation to a New Host. J Virol 87: 4330-4338.